Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 54Neoplasms 38Lung Neoplasms 25Colorectal Neoplasms 24Prostatic Neoplasms 17Uterine Cervical Neoplasms 14Motor Activity 13Colonic Neoplasms 11Pancreatic Neoplasms 10Carcinoma, Non-Small-Cell Lung 10Rectal Neoplasms 9Hematologic Neoplasms 9Anxiety Disorders 9Urinary Bladder Neoplasms 8Obesity 8Melanoma 8Lymphoma 8Depression 8Ovarian Neoplasms 7Endometrial Neoplasms 7Vulvar Neoplasms 6Neoplasm Metastasis 6Head and Neck Neoplasms 6Breast Carcinoma In Situ 6Sarcoma 5Papillomavirus Infections 5Pain 5Leukemia, Myeloid, Acute 5Hematopoietic and Lymphatic System Neoplasm 5Triple Negative Breast Neoplasms 4

Interventions

Tobacco Use Cessation Devices 2Varenicline 1Tomography, X-Ray Computed 1Tobacco Products 1Smoking Devices 1Nicotine Replacement Therapy 1Methods 1Media Exposure 1Magnetic Resonance Spectroscopy 1Lactation 1Fluorodeoxyglucose F18 1Fitness Trackers 1Cycloserine 14-fluoroglutamine 14-(3-fluoropropyl)glutamic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cigarette Smoking × Methods × Clear all
NCT06945120 2026-03-13

ACT Lung Health Intervention: Phase Two

Dana-Farber Cancer Institute

Phase NA Recruiting
50 enrolled

Cigarette Smoking, Tobacco Smoking, Smoking, Smoking Cessation, Behavior, Addictive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡